Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy

Yi-Ming Chen; Wen-Nan Huang; Tsai-Ling Liao; Jun-Pen Chen; Sheng-Shun Yang; Hsin-Hua Chen; Tsu-Yi Hsieh; Wei-Ting Hung; Yi-Hsing Chen; Der-Yuan Chen

doi:10.1136/annrheumdis-2018-214400

Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy

Ann Rheum Dis. 2019 Jun;78(6):849-850. doi: 10.1136/annrheumdis-2018-214400. Epub 2019 Jan 3.

Authors

Yi-Ming Chen^{1

2

3

4}, Wen-Nan Huang^{1

3}, Tsai-Ling Liao^{2

4}, Jun-Pen Chen², Sheng-Shun Yang^{3

5}, Hsin-Hua Chen^{1

2

3

4}, Tsu-Yi Hsieh¹, Wei-Ting Hung¹, Yi-Hsing Chen^{6

3}, Der-Yuan Chen^{7

8}

Affiliations

¹ Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.
² Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
³ Faculty of Medicine, National Yang Ming University, Taipei, Taiwan.
⁴ Institute of Biomedical Science and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
⁵ Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.
⁶ Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan dychen@vghtc.gov.tw ysanne@vghtc.gov.tw.
⁷ Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan dychen@vghtc.gov.tw ysanne@vghtc.gov.tw.
⁸ School of Medicine, China Medical University, Taichung, Taiwan.

PMID: 30606739
DOI: 10.1136/annrheumdis-2018-214400

No abstract available

Keywords: DMARDs (biologic); DMARDs (synthetic); infections; rheumatoid arthritis.

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Abatacept / pharmacology
Aged
Antibodies, Monoclonal, Humanized / pharmacology
Antirheumatic Agents / pharmacology*
Arthritis, Rheumatoid / drug therapy*
Female
Hepacivirus / physiology*
Hepatitis C, Chronic / virology
Humans
Male
Middle Aged
Piperidines / pharmacology
Prospective Studies
Pyrimidines / pharmacology
Pyrroles / pharmacology
Virus Replication / drug effects*

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Piperidines
Pyrimidines
Pyrroles
Abatacept
tofacitinib
tocilizumab